Paradromics implants first patient with motor neuron disease for speech restoration
Key Questions
Who is the first patient implanted by Paradromics and what condition do they have?
The patient is a woman with motor neuron disease who cannot speak clearly. Paradromics performed the implantation as part of its clinical efforts to restore speech using brain-computer interface technology.
What technology was used in Paradromics' first human implant?
The procedure used a fully implantable 421-microwire array with a high data rate. This represents a major milestone for Paradromics as a new contender in clinical BCI for speech restoration.
When will results from the Paradromics implant be available?
Performance metrics such as words per minute and accuracy are still pending. Results are expected within months, and the study includes an ambitious 6-year safety follow-up period.
Paradromics has implanted its first patient, a woman with motor neuron disease who cannot speak clearly, using a fully implantable 421-microwire array with high data rate. This is a major milestone for a new contender in clinical BCI for speech restoration. Performance metrics (wpm/accuracy) are pending; results expected in months. The 6-year safety follow-up is ambitious.